FDA approves dual-energy ablation tech from Johnson & Johnson

Marketplace

Please login to access the CRTOnline.

FDA approves dual-energy ablation tech from Johnson & Johnson

Johnson & Johnson MedTech has secured U.S. Food and Drug Administration (FDA) approval for its Dual-Energy ThermoCool SmartTouch SF (DE STSF) Platform that delivers both radiofrequency (RF) and pulsed field (PF) energy through a single catheter.

Basics of Physiology

Women’s Cardiovascular Risk Requires Earlier Identification, Review Suggests

Coronary Artery Calcium Score of Zero Is Still Reassuring When Lp(a) Is High: Cohort Study

LV Unloading With Microaxial Pump During Complex PCI Does Not Improve Outcomes: CHIP-BCIS3 Substudy

Microvascular Disease

RADPAD Device Lowers Radiation Exposure for Interventional Operators in Randomized Study

Complete vs Culprit Lesion Revascularization is Best Strategy for Older STEMI Patients with Multivessel Disease, EARTH-STEMI Meta-Analysis Finds

EROSION III: OCT Guidance Cuts Stent Implantation Rate 15% vs. Angiographic Guidance in STEMI Patients Undergoing PPCI

Lessons Learned from 800+ Patients Treated with Tricuspid TEER: Update from the TRILUMINATE Pivotal Trial

iFR Works in Guiding Revascularization, Studies Find

Explore the Site

Stay Connected

CRT Group Foundation is a not for profit corporation dedicated to providing educational services in the field of cardiology through the website, CRTonline.org and the Cardiovascular Research Technologies (CRT) annual symposium. CRT focuses on the advances and changes in the field of cardiovascular medicine. CRT is designed to provide access to the world’s leading clinicians and the latest research in order to improve practice and treatment outcomes for a variety of health care professionals.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details

Marketplace

FDA approves dual-energy ablation tech from Johnson & Johnson

Explore the Site

Stay Connected